SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 86 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 1.76 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $14,000 | -33.3% | 58,386 | 0.0% | 0.00% | – |
| Q4 2015 | $21,000 | -79.4% | 58,386 | 0.0% | 0.00% | – |
| Q3 2015 | $102,000 | -21.5% | 58,386 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $130,000 | +39.8% | 58,386 | +21.6% | 0.00% | – |
| Q1 2015 | $93,000 | -30.1% | 48,005 | -4.7% | 0.00% | -100.0% |
| Q4 2014 | $133,000 | -10.7% | 50,368 | +1.5% | 0.00% | 0.0% |
| Q3 2014 | $149,000 | -17.7% | 49,620 | +12.3% | 0.00% | 0.0% |
| Q2 2014 | $181,000 | +9.7% | 44,193 | +15.1% | 0.00% | 0.0% |
| Q1 2014 | $165,000 | -17.9% | 38,383 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $201,000 | -1.0% | 38,383 | +19.3% | 0.00% | 0.0% |
| Q3 2013 | $203,000 | +32.7% | 32,182 | +4.8% | 0.00% | 0.0% |
| Q2 2013 | $153,000 | – | 30,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
| Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
| CAXTON CORP | 57,000 | $99,000 | 0.13% |
| Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
| TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
| Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
| LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
| Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |